We are live on
!
Find out more
BA
Bristlecone Advisors Portfolio holdings
AUM
$1.2B
1-Year Est. Return
19.79%
This Fund
S&P 500
This Quarter
Est. Return
+8%
1 Year Est. Return
+19.79%
3 Year Est. Return
+102.73%
5 Year Est. Return
+112.96%
10 Year Est. Return
+315.34%
AUM
$739M
AUM Growth
+$77.1M
(+12%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
218
New
12
Increased
130
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LONA
LeonaBio Inc
LONA
|
+$13.3M |
| 2 |
Goldman Sachs Access Ultra Short Bond ETF
GSST
|
+$2.32M |
| 3 |
Palantir
PLTR
|
+$1.94M |
| 4 |
Microsoft
MSFT
|
+$1.69M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$3.57M |
| 2 |
Fortinet
FTNT
|
+$3.46M |
| 3 |
RTX Corp
RTX
|
+$2.14M |
| 4 |
Colgate-Palmolive
CL
|
+$1.8M |
| 5 |
Novartis
NVS
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.99% |
| 2 | Consumer Discretionary | 6.35% |
| 3 | Healthcare | 6% |
| 4 | Financials | 5.72% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AvalonBay Communities
AVB
$27.1B
| $470K | 0.06% |
2,251
| – | – |
|
152
SPDR Gold Trust
GLD
$132B
| $461K | 0.06% |
2,782
+945
| +51% | +$161K |
|
153
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.83B
| $449K | 0.06% |
1,834
+296
| +19% | +$67.7K |
|
154
Abbott
ABT
$180B
| $439K | 0.06% |
3,790
-50
| -1% | -$5.83K |
|
155
iShares Russell 1000 ETF
IWB
$47.7B
| $435K | 0.06% |
1,796
+208
| +13% | +$49K |
|
156
iShares Core US Aggregate Bond ETF
AGG
$138B
| $429K | 0.06% |
3,720
+716
| +24% | +$82K |
|
157
Pfizer
PFE
$140B
| $421K | 0.06% |
10,742
-47
| -0.4% | -$1.83K |
|
158
Lennar Class A
LEN
$20.4B
| $420K | 0.06% |
4,372
+52
| +1% | +$5.02K |
|
159
Zscaler
ZS
$23B
| $420K | 0.06% |
1,942
+43
| +2% | +$8.18K |
|
|
ABMD
160
DELISTED
Abiomed Inc
ABMD
| $419K | 0.06% |
1,341
+14
| +1% | +$4.29K |
|
161
McKesson
MCK
$98.5B
| $404K | 0.05% |
2,111
| – | – |
|
162
iShares Select Dividend ETF
DVY
$24B
| $403K | 0.05% |
3,459
+58
| +2% | +$6.9K |
|
163
Sun Communities
SUI
$15B
| $399K | 0.05% |
2,330
+30
| +1% | +$4.97K |
|
164
Humana
HUM
$46.7B
| $398K | 0.05% |
899
| – | – |
|
165
Lockheed Martin
LMT
$134B
| $395K | 0.05% |
1,043
-2
| -0.2% | -$769 |
|
166
Sprouts Farmers Market
SFM
$7.04B
| $393K | 0.05% |
15,822
+194
| +1% | +$5.18K |
|
167
State Street Energy Select Sector SPDR ETF
XLE
$39.7B
| $386K | 0.05% |
14,328
| – | – |
|
168
Okta
OKTA
$24.1B
| $384K | 0.05% |
1,571
+37
| +2% | +$8.93K |
|
169
Coca-Cola
KO
$354B
| $378K | 0.05% |
6,986
| – | – |
|
170
iShares Russell 1000 Growth ETF
IWF
$122B
| $377K | 0.05% |
5,552
+440
| +9% | +$28.4K |
|
171
Stryker
SYK
$127B
| $369K | 0.05% |
1,420
| – | – |
|
172
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
| $340K | 0.05% |
4,505
| – | – |
|
173
Fiverr
FVRR
$376M
| $336K | 0.05% |
1,386
+35
| +3% | +$7.26K |
|
|
MMP
174
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $328K | 0.04% |
6,710
| – | – |
|
175
Neurocrine Biosciences
NBIX
$17.7B
| $324K | 0.04% |
3,326
+85
| +3% | +$8.15K |
|
Similar funds
WCWM
P
SFI
BCM
SAM
4CM
SAM
SIMG
Bristlecone Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Bristlecone Advisors held 218 positions worth $739M, up 12% from $662M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Bristlecone Advisors deployed $29M of net new capital in Q2 2021, opening 12 new positions and adding to 130 existing holdings. Its largest new stake was LeonaBio Inc: 76,156 shares worth $7.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $1.8M trimmed.
- Bristlecone Advisors's largest Q2 2021 buy was LeonaBio Inc: 76,156 shares worth $7.8M.
- Bristlecone Advisors added most to Goldman Sachs Access Ultra Short Bond ETF in Q2 2021, an estimated $2.32M increase.
- Bristlecone Advisors's biggest Q2 2021 reduction was Colgate-Palmolive, cutting an estimated $1.8M.
- Bristlecone Advisors fully exited Travelers Companies in Q2 2021, selling an estimated $3.57M.
- Bristlecone Advisors's ten largest holdings make up 40% of its $739M portfolio in Q2 2021.
- Bristlecone Advisors opened 12 new positions and closed 5 in Q2 2021.
- Bristlecone Advisors's portfolio value rose 12% quarter-over-quarter to $739M.
Based on Bristlecone Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.